N/A
Completed N=92
Evaluation of the Efficacy in Decreasing Myopia Progression of the Proposed Ophthalmic Lens Prototypes
Source: ClinicalTrials.gov NCT05250206 ↗Enrolled (actual)
92
Serious AEs
0.0%
Results posted
Jun 2025
Primary outcomePrimary: Axial Lenght Increase — 0.27; 0.37 mm
Summary
Evaluation of the efficacy in decreasing myopia progression of the proposed ophthalmic lens prototypes.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Axial Lenght Increase |
0.27; 0.37 | — |
Eligibility Criteria
Inclusion Criteria
- Age: 5 to 12 years old
- Myopia (spherical equivalent with cycloplegic) ≤ -0.50D
- Astigmatism < 1.50D
- Anisometropia < 1.50D
- Best-corrected visual acuity ≥ 20/20
Exclusion Criteria
- Patients who have received any previous treatment for myopia control, including the use of RPG contact lenses.
- Participants with ocular pathology such as retinal detachment.
- Participants using drugs that may affect pupillary size and accommodation or that produce effects on the ocular surface.
- Participants with systemic diseases that may affect vision.
Data sourced from ClinicalTrials.gov (NCT05250206). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.